The diagnosis of many cases of acute HEV hepatitis in non-immunocompromised patients in our area, during the last couple of years, prompted us to look systematically for HEV in solid-organ transplant patients with unexplained hepatitis.
Even though two cases of persistent hepatitis E virus infection have been previously reported, HEV was considered to be responsible for acute hepatitis that does not become chronic
Prevalence of anti-HEV IgG
• All patients who received a kidney (n= 241) or liver (n=86) transplant between 01-01-2004 and 12-31-2006 in our department were screened for hepatitis E virus infection at the time of transplantation.
• Prevalence of anti-hepatitis E virus IgG was 13.5 % -14.5 % in patients undergoing a kidney transplantation -10.4 % in patients undergoing a liver transplantation Between 01-01-2004 and 12-31-2006 , all liver-, kidney-and kidneypancreas-transplant patients attending our out-patient and in-patient clinics, and who presented with acute elevation of liver-enzyme levels, were screened for hepatitis E virus infection using molecular tools, after all other causes of hepatitis have been ruled out.
Patients with chronic active hepatitis B, C, and D viruses were not considered for this study Serum HEV RNA was assessed in 217 patients, and was found to be positive in the serum of 14 patients (6.45%). None of the patients had traveled abroad during the year before the hepatitis episode
No abnormality was evidenced on physical examination Biliary-tract complications were ruled out by abdominal ultrasonography.
Toxic-and drug-related causes were also ruled out by anamnesis.
Clinical Presentation
All classical causes of hepatitis were ruled out: hepatitis A, B, C, CMV, EBV, auto-immune hepatitis At transplantation, and 6 to 12 months before the acute phase,
IgG anti-HEV and serum HEV RNA were negative in ALL patients
Phylogenetic analysis revealed that all strains belong to genotype 3
⇒ Diagnosis: Acute hepatitis E infection
Immunosuppressive therapy was not modified.
In six patients (43%), serum and stool HEV RNA became undetectable within 6 months, and remained negative until the last follow-up, i.e., 12 (5-36) months (resolving HEV infection group)
In eight other patients (57%), HEV infection evolved to chronic hepatitis: confirmed by the presence of persisting elevated liver-enzyme levels and positive serum HEV RNA at 15 (10 -24) months after the acute phase (chronic HEV infection group).
Outcome of HEV infection 
